{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:02:15Z","timestamp":1791194535525,"version":"4.1.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T00:00:00Z","timestamp":1358899200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0054595","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T21:53:42Z","timestamp":1358978022000},"page":"e54595","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Suppression of AKT Anti-Apoptotic Signaling by a Novel Drug Candidate Results in Growth Arrest and Apoptosis of Hepatocellular Carcinoma Cells"],"prefix":"10.1371","volume":"8","author":[{"given":"Andrea","family":"Cuconati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cally","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenquan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,1,23]]},"reference":[{"key":"ref1","unstructured":"Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, <etal>et al<\/etal>. (2008) SEER Cancer Statistics Review, 1975\u20132005. National Cancer Institute."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","journal-title":"Int J Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"CD Mathers","year":"2006","journal-title":"PLoS Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-139-10-200311180-00009","article-title":"The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update","volume":"139","author":"HB El-Serag","year":"2003","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00535-008-2258-6","article-title":"The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology","volume":"44","author":"S Caldwell","year":"2009","journal-title":"J Gastroenterol"},{"key":"ref6","unstructured":"Kew M (2006) Hepatic tumors and cysts. In: Feldman M FL, Sleisenger MH, editor. Sleisenger &amp; Fordtran\u2019s Gastrointestinal and Liver Disease. 8th ed. Philadelphia: Saunders Elsevier."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/jhep.2001.21041","article-title":"Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States","volume":"33","author":"HB El-Serag","year":"2001","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1200\/JCO.2005.03.196","article-title":"Hepatocellular carcinoma: the need for progress","volume":"23","author":"MB Thomas","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"JM Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"ref10","first-page":"3858","article-title":"Growth of human hepatoma cells lines with differentiated functions in chemically defined medium","volume":"42","author":"H Nakabayashi","year":"1982","journal-title":"Cancer Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1084\/jem.97.5.695","article-title":"Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix","volume":"97","author":"WF Scherer","year":"1953","journal-title":"J Exp Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.6248960","article-title":"Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen","volume":"209","author":"BB Knowles","year":"1980","journal-title":"Science"},{"key":"ref13","first-page":"5379","article-title":"Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors","volume":"43","author":"TC Hamilton","year":"1983","journal-title":"Cancer Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0006-291X(79)91250-6","article-title":"Estradiol induced proteins in the MCF7 human breast cancer cell line","volume":"90","author":"B Westley","year":"1979","journal-title":"Biochem Biophys Res Commun"},{"key":"ref15","first-page":"115","article-title":"The LNCaP cell line\u2013a new model for studies on human prostatic carcinoma","volume":"37","author":"JS Horoszewicz","year":"1980","journal-title":"Prog Clin Biol Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"P Gripon","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3748\/wjg.v7.i5.630","article-title":"Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97","volume":"7","author":"Y Li","year":"2001","journal-title":"World J Gastroenterol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1073\/pnas.90.11.5123","article-title":"Simian virus 40 large tumor antigen-immortalized normal human liver epithelial cells express hepatocyte characteristics and metabolize chemical carcinogens","volume":"90","author":"AM Pfeifer","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF02723678","article-title":"Cell lines from non-neoplastic liver and hepatocellular carcinoma tissue from a single patient","volume":"32","author":"M Noguchi","year":"1996","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"CA Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nchembio873","article-title":"Chemical genetics reveals a complex functional ground state of neural stem cells","volume":"3","author":"P Diamandis","year":"2007","journal-title":"Nat Chem Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/mol.107.035113","article-title":"Building a pharmacological lexicon: small molecule discovery in academia","volume":"72","author":"JS Lazo","year":"2007","journal-title":"Mol Pharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1747-0285.2006.00391.x","article-title":"Searching for new antimalarial therapeutics amongst known drugs","volume":"67","author":"JL Weisman","year":"2006","journal-title":"Chem Biol Drug Des"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nchembio806","article-title":"A clinical drug library screen identifies astemizole as an antimalarial agent","volume":"2","author":"CR Chong","year":"2006","journal-title":"Nat Chem Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"T Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0272-2712(18)30276-2","article-title":"Hepatitis B and C viruses and hepatocellular carcinoma","volume":"16","author":"MC Kew","year":"1996","journal-title":"Clin Lab Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc1819","article-title":"Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis","volume":"6","author":"M Cully","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/cncr.11266","article-title":"Expression and prognostic role of tumor suppressor gene PTEN\/MMAC1\/TEP1 in hepatocellular carcinoma","volume":"97","author":"TH Hu","year":"2003","journal-title":"Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cncr.20774","article-title":"Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma","volume":"103","author":"K Nakanishi","year":"2005","journal-title":"Cancer"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/156800908783497140","article-title":"Deregulation of the Akt pathway in human cancer","volume":"8","author":"E Tokunaga","year":"2008","journal-title":"Curr Cancer Drug Targets"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1158\/0008-5472.CAN-08-0257","article-title":"Down-regulation of phospho-Akt is a major molecular determinant of bortezomib-induced apoptosis in hepatocellular carcinoma cells","volume":"68","author":"KF Chen","year":"2008","journal-title":"Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cellsig.2009.01.004","article-title":"Akt-dependent and -independent mechanisms of mTOR regulation in cancer","volume":"21","author":"RM Memmott","year":"2009","journal-title":"Cell Signal"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/onc.2009.401","article-title":"Rictor is a novel target of p70 S6 kinase-1","volume":"29","author":"C Treins","year":"2010","journal-title":"Oncogene"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1128\/MCB.00601-09","article-title":"mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling","volume":"30","author":"LA Julien","year":"2010","journal-title":"Mol Cell Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1128\/MCB.00735-09","article-title":"Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1","volume":"29","author":"CC Dibble","year":"2009","journal-title":"Mol Cell Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1593\/neo.10804","article-title":"Development of a resistance-like phenotype to sorafenib by human hepatocellular carcinoma cells is reversible and can be delayed by metronomic UFT chemotherapy","volume":"12","author":"TC Tang","year":"2010","journal-title":"Neoplasia"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hep.21467","article-title":"Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets","volume":"45","author":"S Boyault","year":"2007","journal-title":"Hepatology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1002\/hep.21063","article-title":"Functional genomics of hepatocellular carcinoma","volume":"43","author":"SS Thorgeirsson","year":"2006","journal-title":"Hepatology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/ng0802-339","article-title":"Molecular pathogenesis of human hepatocellular carcinoma","volume":"31","author":"SS Thorgeirsson","year":"2002","journal-title":"Nat Genet"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.1073\/pnas.95.15.8847","article-title":"Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas","volume":"95","author":"A de La Coste","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/scbi.2000.0319","article-title":"Genetics of hepatocellular carcinoma","volume":"10","author":"MA Buendia","year":"2000","journal-title":"Semin Cancer Biol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1582-4934.2005.tb00337.x","article-title":"The activation of Akt\/PKB signaling pathway and cell survival","volume":"9","author":"G Song","year":"2005","journal-title":"J Cell Mol Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1042\/bst0320350","article-title":"Physiological functions of protein kinase B\/Akt","volume":"32","author":"ZZ Yang","year":"2004","journal-title":"Biochem Soc Trans"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3748\/wjg.15.513","article-title":"Dysregulation of apoptosis in hepatocellular carcinoma cells","volume":"15","author":"I Fabregat","year":"2009","journal-title":"World J Gastroenterol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1478-3231.2006.01409.x","article-title":"Survival and apoptosis: a dysregulated balance in liver cancer","volume":"27","author":"I Fabregat","year":"2007","journal-title":"Liver Int"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"7971","DOI":"10.1038\/sj.onc.1205919","article-title":"P53 mutation as a source of aberrant beta-catenin accumulation in cancer cells","volume":"21","author":"T Cagatay","year":"2002","journal-title":"Oncogene"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1021\/jm901457w","article-title":"Hay MP, Turcotte S, Flanagan JU, Bonnet M, Chan DA, et al. 4-Pyridylanilinothiazoles that selectively target von Hippel-Lindau deficient renal cell carcinoma cells by inducing autophagic cell death","volume":"53","journal-title":"J Med Chem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1016\/j.bmcl.2008.08.023","article-title":"Initial SAR studies on apamin-displacing 2-aminothiazole blockers of calcium-activated small conductance potassium channels","volume":"18","author":"RG Gentles","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1128\/JVI.02145-09","article-title":"Discovery of 2-aminothiazoles as potent antiprion compounds","volume":"84","author":"S Ghaemmaghami","year":"2010","journal-title":"J Virol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/jm101250y","article-title":"2-Aminothiazoles as therapeutic leads for prion diseases","volume":"54","author":"A Gallardo-Godoy","year":"2011","journal-title":"J Med Chem"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0054595","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T20:32:38Z","timestamp":1562617958000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0054595"}},"subtitle":[],"editor":[{"given":"Zhiyuan","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,23]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0054595","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,23]]}}}